Anzeige
Mehr »
Login
Donnerstag, 25.04.2024 Börsentäglich über 12.000 News von 687 internationalen Medien
Wie die Revolution der sauberen Energie eine solide Investitionsmöglichkeit bieten könnte
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
Dow Jones News
231 Leser
Artikel bewerten:
(0)

Aladdin Blockchain Technologies Holding SE: Aladdin creates a prototype for Diabetic Retinopathy using artificial intelligence (AI) with 94% accuracy

DGAP-Media / 09.08.2018 / 12:47
Diabetes is now a disease which affects c425 million people globally, according to the International Diabetes Federation. Close to half of those with diabetes will experience retinopathy, a result of which can be blindness if not detected at an early stage.
 
Aladdin has developed a prototype which uses an artificial intelligence-based grading algorithm to detect, with high reliability and accuracy, referable diabetic retinopathy.
 
Using 37,266 retinal images, of which 80% were used to train the Deep Neural Networks Algorithms and 20% were used to validate the performance, Aladdin's AI/ML team were able to teach the prototype to identify diabetes patients from healthy patients with the following high reliability:
 
Accuracy to distinguish Normal/Diabetic Retinopathy: 94.3%
Accuracy to distinguish No-Proliferative/Proliferative: 96.7%
 
Furthermore, the prototype can distinguish the different stages of diabetes (None, Mild, Moderate, Severe, Proliferative) to 84.1% accuracy. These are exciting results at such an early stage of development. Aladdin's AI/ML team will now work to further the accuracy and reliability of the prototype using the increasing amounts of data on Aladdin's platform.
 
This development is particularly pertinent as the US Food and Drug Administration (FDA) approved, in April this year, the first software powered by artificial intelligence that replaces the need for a specialized doctor to interpret medical imagery. Validating the assumption that there is significant demand for these technologies within the healthcare industry.
 
 
Wade Menpes-Smith (Chairman)


End of Media Release

Issuer: Aladdin Blockchain Technologies Holding SE
Key word(s): Health

09.08.2018 Dissemination of a Press Release, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de
Language: 	English
Company: 	Aladdin Blockchain Technologies Holding SE
	Unter den Linden 10
	10117 Berlin
	Germany
Phone: 	030 700140449
E-mail: 	info@aladdinid.com
Internet: 	www.aladdinid.com
ISIN: 	DE000A12ULL2
WKN: 	A12ULL
Listed: 	Regulated Unofficial Market in Dusseldorf

 
End of News 	DGAP Media
Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2018 Dow Jones News
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.